Original language | English |
---|---|
Pages (from-to) | 4-6 |
Number of pages | 3 |
Journal | Clinical Microbiology and Infection |
Volume | 30 |
Issue number | 1 |
DOIs |
|
Publication status | Published - Jan 2024 |
Externally published | Yes |
Bibliographical note
Funding Information:This study received funding from the European Centre for Disease Prevention and Control , Stockholm, Sweden (grant ECDC/GRANT/2018/001 ). FPM was supported by a financial grant from Mukoviszidose Institut gGmbH, Bonn, the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V (project number 2004).
Funding Information:
This study received funding from the European Centre for Disease Prevention and Control, Stockholm, Sweden (grant ECDC/GRANT/2018/001). FPM was supported by a financial grant from Mukoviszidose Institut gGmbH, Bonn, the research and development arm of the German Cystic Fibrosis Association Mukoviszidose e.V (project number 2004).
Keywords
- Antimycobacterial susceptibility
- Diagnosis
- Mycobacteria
- Surveillance
- Testing
- Whole genome sequencing